Prediabetes

Clinical Trial Finder

Many patients with prediabetes are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Lifestyle-Related Health Outcomes in Prediabetes and Diabetes

Conditions:   Obesity;   Prediabetic State;   Type 2 Diabetes
Interventions:   Behavioral: Health Education and Coaching Strategy;   Behavioral: Dietary consult
Sponsors:   Indiana University;   Purdue University
Recruiting - verified August 2015

Retroperitoneal Lymph Node Dissection in Treating Patients With Stage I-IIA Testicular Seminoma

Conditions:   Lymphadenopathy;   Stage I Testicular Seminoma;   Stage II Testicular Seminoma
Interventions:   Other: Laboratory Biomarker Analysis;   Procedure: Retroperitoneal Lymph Node Dissection
Sponsors:   University of Southern California;   National Cancer Institute (NCI)
Recruiting - verified August 2015

Modulating Effects of Oil Palm Phenolics in Subjects With Pre-diabetes

Condition:   Prediabetes
Interventions:   Dietary Supplement: Oil Palm Phenolics;   Dietary Supplement: Placebo
Sponsors:   University of Science Malaysia;   Malaysia Palm Oil Board;   Clinical Research Centre, Malaysia
Not yet recruiting - verified August 2015

Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)

Conditions:   Rheumatoid Arthritis;   Insulin Resistance
Interventions:   Other: Active Comparator;   Drug: Pioglitazone;   Drug: Placebo
Sponsor:   Beatriz Hanaoka
Not yet recruiting - verified August 2015

Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women

Condition:   Diabetes Prevention in Women After GDM Who Are at High-risk
Interventions:   Drug: DAPA/MET XR;   Drug: DAPA;   Drug: MET XR
Sponsors:   Woman's;   AstraZeneca
Recruiting - verified August 2015

ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD

Conditions:   Prediabetic State;   Non-alcoholic Fatty Liver Disease;   Type 2 Diabetes Mellitus
Interventions:   Drug: Cenicriviroc 150 mg;   Drug: Matching placebo
Sponsor:   Tobira Therapeutics, Inc.
Enrolling by invitation - verified August 2015

The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure

Conditions:   Kidney Failure, Chronic;   Prediabetic State
Interventions:   Drug: Liraglutide;   Drug: Placebo
Sponsors:   Bo Feldt-Rasmussen;   Novo Nordisk A/S;   The GCP unit at Copenhagen University Hospital
Withdrawn - verified August 2015

The Effects of Potassium on Glucose Metabolism in African Americans

Condition:   Borderline Hypokalemia
Interventions:   Drug: K+ supplement;   Drug: Placebo
Sponsor:   Duke University
Recruiting - verified August 2015

Comparing Glycaemic Benefits of Active Versus Passive Lifestyle Intervention in Kidney Allograft Recipients

Conditions:   Post Transplantation Diabetes Mellitus;   Obesity;   Transplantation of Kidney
Intervention:   Behavioral: Active lifestyle intervention
Sponsor:   University Hospital Birmingham NHS Foundation Trust
Recruiting - verified August 2015

Assessing the Effectiveness of a Weight Watchers-based Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes

Conditions:   Prediabetes;   Gestational Diabetes Mellitus;   Obesity
Interventions:   Behavioral: Weight Watchers;   Behavioral: National Diabetes Education Program
Sponsors:   Indiana University;   Weight Watchers International;   Indiana Clinical and Translational Sciences Institute;   National Diabetes Education Program
Active, not recruiting - verified August 2015

Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes

Conditions:   Type 2 Diabetes;   Cardiovascular Disease
Interventions:   Drug: Sitagliptin;   Drug: Glimepiride;   Drug: Placebo;   Drug: Placebo
Sponsors:   University of Colorado, Denver;   Merck Sharp & Dohme Corp.
Recruiting - verified August 2015

Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals

Condition:   Obesity
Intervention:   Drug: Roflumilast
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Suspended - verified August 2015

Encourage Healthy Families

Conditions:   Gestational Diabetes Mellitus;   Pre-diabetes
Intervention:   Behavioral: Diabetes Prevention Program (DPP)
Sponsors:   Indiana University;   The JPB Foundation;   The YMCA of Greater Indianapolis;   Regenstrief Institute, Inc.;   Indiana Clinical and Translational Sciences Institute
Active, not recruiting - verified August 2015

Effect of Diet and Physical Activity on Incidence of Type 2 Diabetes

Conditions:   Pre-diabetes;   Obesity
Interventions:   Behavioral: High protein/ high intensity physical activity (HP-HI);   Behavioral: High protein / moderate intensity physical activity (HP-MI);   Behavioral: Moderate protein/ high intensity physical activity (MP-HI);   Behavioral: Moderate protein/ moderate intensity physical activity (MP-MI)
Sponsors:   Anne Birgitte Raben;   Helsinki University;   Maastricht University;   University of Nottingham;   University of Navarra;   Clinical Center of Endocrinology, Medical University, Sofia, Bulgaria;   University of Sydney;   University of Auckland, New Zealand;   University of Stuttgart;   Swansea University;   Cambridge Manufacturing Company Limited;   European Union
Active, not recruiting - verified August 2015

A Survey on the Rate of Glucose Intolerance in Hong Kong Chinese

Conditions:   Diabetes;   Impaired Glucose Tolerance (IGT);   Impaired Fasting Glucose (IFG);   Glucose Intolerance
Intervention:   Other: observational: no treatment involved
Sponsor:   Chinese University of Hong Kong
Active, not recruiting - verified August 2015

A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong

Conditions:   Prediabetes;   Cardiovascular Risk Factors
Intervention:   Other: observational, no intervention needed
Sponsor:   Chinese University of Hong Kong
Active, not recruiting - verified August 2015

A Survey to Evaluate the Rate of Abnormal Glucose Tolerance Among Hong Kong Chinese Subjects With Coronary Heart Disease

Conditions:   Coronary Heart Disease;   Diabetes Mellitus
Intervention:  
Sponsor:   Chinese University of Hong Kong
Withdrawn - verified August 2015

Get CardioSmart

You're Invited